174 related articles for article (PubMed ID: 34148794)
21. Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma.
Winner M; Goff SL; Chabot JA
Semin Oncol; 2015 Feb; 42(1):86-97. PubMed ID: 25726054
[TBL] [Abstract][Full Text] [Related]
22. [Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version)].
Pancreatic Cancer Committee of Chinese Anticancer Association
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):81-100. PubMed ID: 33378799
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence.
O'Reilly D; Fou L; Hasler E; Hawkins J; O'Connell S; Pelone F; Callaway M; Campbell F; Capel M; Charnley R; Corrie P; Elliot D; Goodburn L; Jewell A; Joharchi S; McGeeney L; Mukherjee S; Oppong K; Whelan P; Primrose J; Neoptolemos J
Pancreatology; 2018 Dec; 18(8):962-970. PubMed ID: 30292643
[TBL] [Abstract][Full Text] [Related]
24. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
25. Medical oncology and pancreatic cancer: what the radiologist needs to know.
Fogelman DR; Varadhachary G
Abdom Radiol (NY); 2018 Feb; 43(2):383-392. PubMed ID: 29285600
[TBL] [Abstract][Full Text] [Related]
26. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
27. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
28. [Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2018 version)].
Pancreatic Cancer Committee of Chinese Anti-Cancer Association
Zhonghua Wai Ke Za Zhi; 2018 Jul; 56(7):481-494. PubMed ID: 30032527
[TBL] [Abstract][Full Text] [Related]
29. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant and neoadjuvant treatment in pancreatic cancer.
Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
World J Gastroenterol; 2012 Apr; 18(14):1565-72. PubMed ID: 22529684
[TBL] [Abstract][Full Text] [Related]
31. Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis.
Okusaka T; Nakamura M; Yoshida M; Kitano M; Uesaka K; Ito Y; Furuse J; Hanada K; Okazaki K;
Pancreas; 2020 Mar; 49(3):326-335. PubMed ID: 32132516
[TBL] [Abstract][Full Text] [Related]
32. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G
BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927
[TBL] [Abstract][Full Text] [Related]
33. [The S3 guideline exocrine pancreatic cancer].
Seufferlein T; Adler G
Med Klin (Munich); 2009 Nov; 104(11):869-74. PubMed ID: 19916076
[TBL] [Abstract][Full Text] [Related]
34. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.
Choi JG; Nipp RD; Tramontano A; Ali A; Zhan T; Pandharipande P; Dowling EC; Ferrone CR; Hong TS; Schrag D; Fernandez-Del Castillo C; Ryan DP; Kong CY; Hur C
Oncologist; 2019 Jul; 24(7):945-954. PubMed ID: 30559125
[TBL] [Abstract][Full Text] [Related]
36. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
37. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
[TBL] [Abstract][Full Text] [Related]
38. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
J Liver Cancer; 2023 Mar; 23(1):1-120. PubMed ID: 37384024
[TBL] [Abstract][Full Text] [Related]
39. Surgical management of pancreatic neoplasms: what's new?
Karachristos A; Esnaola NF
Curr Gastroenterol Rep; 2014 Aug; 16(8):397. PubMed ID: 25064316
[TBL] [Abstract][Full Text] [Related]
40. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
